Skip to main content
SpringerLink
Log in

Subgroups at high and low risk of tofacitinib-related cancer and MACE

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Kristensen LE, et al. Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance. Annals of the Rheumatic Diseases : 17 Mar 2023. Available from: URL: http://doi.org/10.1136/ard-2022-223715

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Subgroups at high and low risk of tofacitinib-related cancer and MACE. Reactions Weekly 1950, 11 (2023). https://doi.org/10.1007/s40278-023-36408-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-36408-0

Search

Navigation